Recent Myocardial Infarction is Associated With Increased Risk in Older Adults With Acute Ischemic Stroke Receiving Thrombolytic Therapy

Recent Myocardial Infarction is Associated With Increased Risk in Older Adults With Acute Ischemic Stroke Receiving Thrombolytic Therapy

Background Intravenous recombinant tissue‐type plasminogen activator (rtPA) remains the only medical therapy to improve outcomes for acute ischemic stroke (AIS), but the safety of rtPA in AIS patients with a history of recent myocardial infarction (MI) remains controversial. Methods and Results We s...

Full description

Bibliographic Details
Main Authors: Taku Inohara, Li Liang, Andrzej S. Kosinski, Eric E. Smith, Lee H. Schwamm, Adrian F. Hernandez, Deepak L. Bhatt, Gregg C. Fonarow, Eric D. Peterson, Ying Xian
Format: Article
Language:English
Published: Wiley 2019-08-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
contraindication
eligibility criteria
recombinant tissue plasminogen activator
stroke
thrombolysis
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.119.012450

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.119.012450

Similar Items